Free Trial

Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Amdocs Limited (NASDAQ:DOX)

Amdocs logo with Computer and Technology background

Key Points

  • Representative Gilbert Ray Cisneros, Jr. sold shares of Amdocs Limited (NASDAQ:DOX) valued between $1,001 and $15,000 on October 1st, 2025.
  • Amdocs announced a quarterly dividend of $0.527, with an ex-dividend date of September 30th, representing an annualized yield of 2.6%.
  • Research firms have given Amdocs an average rating of "Moderate Buy" with a target price of $108.00.
  • MarketBeat previews top five stocks to own in November.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Amdocs Limited (NASDAQ:DOX). In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Amdocs stock on October 1st. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 10/1/2025.
  • Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 9/30/2025.
  • Sold $15,001 - $50,000 in shares of Fortive NYSE: FTV on 9/30/2025.
  • Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 9/30/2025.
  • Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 9/30/2025.
  • Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 9/30/2025.
  • Purchased $1,001 - $15,000 in shares of PTC NASDAQ: PTC on 9/30/2025.
  • Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 9/30/2025.
  • Purchased $1,001 - $15,000 in shares of Mitsubishi Heavy Industries OTCMKTS: MHVYF on 9/30/2025.
  • Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 9/30/2025.

Amdocs Price Performance

NASDAQ:DOX opened at $81.44 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $9.19 billion, a P/E ratio of 16.52, a P/E/G ratio of 1.34 and a beta of 0.51. Amdocs Limited has a 12 month low of $78.61 and a 12 month high of $95.41. The business's 50-day moving average is $84.73 and its 200 day moving average is $87.61.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm's revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.62 earnings per share. On average, equities research analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Tuesday, September 30th. Amdocs's payout ratio is currently 42.80%.

Analysts Set New Price Targets

A number of research firms recently commented on DOX. Weiss Ratings reiterated a "hold (c+)" rating on shares of Amdocs in a research report on Wednesday, October 8th. Wolfe Research began coverage on Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Finally, Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $108.00.

View Our Latest Analysis on Amdocs

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Pzena Investment Management LLC grew its stake in shares of Amdocs by 2.1% during the second quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company's stock valued at $597,719,000 after buying an additional 132,463 shares during the last quarter. LSV Asset Management grew its stake in shares of Amdocs by 6.6% during the second quarter. LSV Asset Management now owns 3,391,510 shares of the technology company's stock valued at $309,441,000 after buying an additional 211,009 shares during the last quarter. Alyeska Investment Group L.P. grew its stake in shares of Amdocs by 38.6% during the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock valued at $213,174,000 after buying an additional 648,693 shares during the last quarter. Brandes Investment Partners LP grew its stake in shares of Amdocs by 1.2% during the second quarter. Brandes Investment Partners LP now owns 2,328,804 shares of the technology company's stock valued at $212,481,000 after buying an additional 27,581 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in shares of Amdocs by 23.5% during the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock valued at $205,219,000 after buying an additional 426,911 shares during the last quarter. Institutional investors own 92.02% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Amdocs

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.